ABOUT USNCE PROJECTSNDDS PROJECTSTIMELINESINVESTORSPRESSCONTACT US


 


Water insoluble anticancers have two issues with their use first, toxic surfactants often have to be used to solubilise the drug; and secondly, such drugs not only reach the tumor tissues but also reach and penetrate healthy tissues in the body.

Our novel self dispersing Nanoparticle technology platform addresses these challenges with higher drug localization to the cancer cells, lesser excipient, and a higher dose

Products made with our technology do not need any pre-administration preparation, such as the administration of antihistamines or steroids, or the use of in-line filters.

Two products are under development, Paclitaxel Injection for nanodispersion (PICN), and Docetaxel Injection for nanodispersion (DICN)

   
Home
About Us
NCE Projects
NDDS Projects
Timelines
Investors
Press
Contact Us
Careers
Site Map